{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T16:05:38Z","timestamp":1791993938053,"version":"4.4.0"},"reference-count":176,"publisher":"MDPI AG","issue":"6","license":[{"start":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T00:00:00Z","timestamp":1779408000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceuticals"],"abstract":"<jats:p>The process of drug discovery is one of the most expensive, time-consuming, and high-risk endeavors in modern science. Translating initial scientific insights into safe and effective therapies, supported by genomics, structural biology, and computational chemistry, typically requires more than a decade and substantial financial investment. Machine learning (ML) has emerged as a powerful tool for improving efficiency across the drug discovery pipeline. By enabling the analysis of large and complex datasets, ML supports target identification, lead discovery, optimization, and prediction of preclinical and clinical outcomes. Its integration with experimental validation and automation is illustrated by recent advances such as protein structure prediction, AI-driven antifibrotic compound discovery, and antibiotic identification. Despite these advances, significant challenges remain. Model generalizability is limited by data scarcity, heterogeneity, and hidden biases. In addition, the translation of in silico predictions into clinically validated outcomes remains a major bottleneck, and regulatory acceptance is constrained by limited model interpretability. Ethical considerations, including data privacy, equitable representation, and the potential misuse of generative models, further complicate adoption. This review examines the applications of ML across the drug discovery pipeline, with a focus on translational and regulatory considerations. It also discusses emerging directions, including hybrid physics\u2013AI approaches, multimodal foundation models, federated learning, and explainable AI. The effective integration of ML will depend on rigorous validation, interdisciplinary collaboration, responsible data governance, and alignment with regulatory frameworks.<\/jats:p>","DOI":"10.3390\/ph19060810","type":"journal-article","created":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:33:54Z","timestamp":1779687234000},"page":"810","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":3,"title":["Harnessing Machine Learning for Accelerated Drug Discovery: Opportunities and Unmet Challenges"],"prefix":"10.3390","volume":"19","author":[{"given":"Mohamed","family":"El-Tanani","sequence":"first","affiliation":[{"name":"RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8454-8158","authenticated-orcid":false,"given":"Syed Arman","family":"Rabbani","sequence":"additional","affiliation":[{"name":"RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1555-2820","authenticated-orcid":false,"given":"Adil Farooq","family":"Wali","sequence":"additional","affiliation":[{"name":"RAK College of Pharmacy, Ras Al Khaimah Medical and Health Sciences University, Ras Al Khaimah 11172, United Arab Emirates"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frezah","family":"Muhana","sequence":"additional","affiliation":[{"name":"Princess Sarvath Community College, Amman 11196, Jordan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yahia","family":"El-Tanani","sequence":"additional","affiliation":[{"name":"Royal Cornwall Hospital Trust, NHS, Truro TR1 3LJ, UK"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kumar","sequence":"additional","affiliation":[{"name":"Amity Institute of Pharmacy, Amity University, Panchgaon, Gurgaon 122412, India"},{"name":"Department of Pharmacy, Jagannath University, Bahadurgarh 124507, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,5,22]]},"reference":[{"key":"ref_1","first-page":"149","article-title":"Revolutionizing pharmaceutical research: Harnessing machine learning for a paradigm shift in drug discovery","volume":"2","author":"Husnain","year":"2023","journal-title":"Int. J. Multidiscip. Sci. Arts"},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1080\/1061186X.2024.2365934","article-title":"Harnessing machine learning potential for personalised drug design and overcoming drug resistance","volume":"32","author":"Hakami","year":"2024","journal-title":"J. Drug Target."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1080\/17568919.2025.2608284","article-title":"Harnessing artificial intelligence and machine learning to accelerate structure-based drug discovery for tuberculosis","volume":"18","author":"Thakur","year":"2026","journal-title":"Future Med. Chem."},{"key":"ref_4","first-page":"18","article-title":"Revolutionizing drug formulation: Harnessing artificial intelligence and machine learning for enhanced stability, formulation optimization, and accelerated development","volume":"8","author":"Dangeti","year":"2023","journal-title":"Int. J. Pharm. Sci. Med."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"29","DOI":"10.36922\/aih.4423","article-title":"Revolutionizing new drug discovery: Harnessing AI and machine learning to overcome traditional challenges and accelerate targeted therapies","volume":"2","author":"Singh","year":"2024","journal-title":"Artif. Intell. Health"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2174\/0113816128298691240222054120","article-title":"Revolutionizing drug discovery: The role of artificial intelligence and machine learning","volume":"30","author":"Verma","year":"2024","journal-title":"Curr. Pharm. Des."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"e40265","DOI":"10.1016\/j.heliyon.2024.e40265","article-title":"Therapeutic peptide development revolutionized: Harnessing the power of artificial intelligence for drug discovery","volume":"10","author":"Hashemi","year":"2024","journal-title":"Heliyon"},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"e202304359","DOI":"10.1002\/slct.202304359","article-title":"The future of ChatGPT in medicinal chemistry: Harnessing AI for accelerated drug discovery","volume":"9","author":"Pradhan","year":"2024","journal-title":"ChemistrySelect"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1007\/s11095-024-03798-9","article-title":"The role of artificial intelligence and machine learning in accelerating the discovery and development of nanomedicine","volume":"41","author":"Agrahari","year":"2024","journal-title":"Pharm. Res."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40364-025-00758-2","article-title":"Integrating artificial intelligence in drug discovery and early drug development: A transformative approach","volume":"13","author":"Ocana","year":"2025","journal-title":"Biomark. Res."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/cpt.3053","article-title":"Artificial intelligence for quantitative modeling in drug discovery and development: An innovation and quality consortium perspective on use cases and best practices","volume":"115","author":"Terranova","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1016\/j.cell.2026.02.012","article-title":"New approach methodologies for drug discovery","volume":"189","author":"Liu","year":"2026","journal-title":"Cell"},{"key":"ref_13","first-page":"101248","article-title":"The future of pharmaceuticals: Artificial intelligence in drug discovery and development","volume":"15","author":"Fu","year":"2025","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"2411325","DOI":"10.1002\/advs.202411325","article-title":"Applications of artificial intelligence in drug repurposing","volume":"12","author":"Wan","year":"2025","journal-title":"Adv. Sci."},{"key":"ref_15","doi-asserted-by":"crossref","unstructured":"Hays, H., and Richardson, W.J. (2026). A Survey of LLMs in Drug Discovery and Precision Medicine. SSRN, preprints.","DOI":"10.2139\/ssrn.6215938"},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1517\/17460441.2011.579100","article-title":"BindingDB and ChEMBL: Online compound databases for drug discovery","volume":"6","author":"Wassermann","year":"2011","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_17","first-page":"1387","article-title":"Exploiting PubChem and other public databases for virtual screening in 2025: What are the latest trends? Expert Opin","volume":"20","year":"2025","journal-title":"Drug Discov."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"D1100","DOI":"10.1093\/nar\/gkr777","article-title":"ChEMBL: A large-scale bioactivity database for drug discovery","volume":"40","author":"Gaulton","year":"2012","journal-title":"Nucleic Acids Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"D1045","DOI":"10.1093\/nar\/gkv1072","article-title":"BindingDB in 2015: A public database for medicinal chemistry, computational chemistry and systems pharmacology","volume":"44","author":"Gilson","year":"2016","journal-title":"Nucleic Acids Res."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Kim, S., and Bolton, E.E. (2024). PubChem: A large-scale public chemical database for drug discovery. Open Access Databases and Datasets for Drug Discovery, Wiley.","DOI":"10.1002\/9783527830497.ch2"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"19800","DOI":"10.1021\/acs.jmedchem.5c00920","article-title":"Drug and Clinical Candidate Drug Data in ChEMBL","volume":"68","author":"Hunter","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"35796","DOI":"10.1109\/ACCESS.2024.3373195","article-title":"Explainable artificial intelligence for drug discovery and development: A comprehensive survey","volume":"12","author":"Alizadehsani","year":"2024","journal-title":"IEEE Access"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"107985","DOI":"10.1016\/j.bioorg.2024.107985","article-title":"Advances in structural identification of some thieno [2, 3-d] pyrimidine scaffolds as antitumor molecules: Synthetic approaches and control programmed cancer cell death potential","volume":"154","author":"Mghwary","year":"2025","journal-title":"Bioorganic Chem."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1007\/s00044-023-03040-y","article-title":"Recent updates on thienopyrimidine derivatives as anticancer agents","volume":"32","author":"Sayed","year":"2023","journal-title":"Med. Chem. Res."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/j.bmc.2019.02.044","article-title":"Thieno [2, 3-d] pyrimidine as a promising scaffold in medicinal chemistry: Recent advances","volume":"27","author":"Ali","year":"2019","journal-title":"Bioorganic Med. Chem."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1007\/s13205-022-03165-8","article-title":"Deep learning tools for advancing drug discovery and development","volume":"12","author":"Nag","year":"2022","journal-title":"3 Biotech."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1080\/17460441.2021.1909567","article-title":"Artificial intelligence in drug discovery: Recent advances and future perspectives","volume":"16","author":"Grisoni","year":"2021","journal-title":"Expert. Opin. Drug Discov."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1007\/s42452-025-06991-6","article-title":"Deep learning and artificial intelligence for drug discovery, application, challenge, and future perspectives","volume":"7","author":"Ali","year":"2025","journal-title":"Discov. Appl. Sci."},{"key":"ref_29","doi-asserted-by":"crossref","unstructured":"Nissan, N., Allen, M.C., Sabatino, D., and Biggar, K.K. (2024). Future perspective: Harnessing the power of artificial intelligence in the generation of new peptide drugs. Biomolecules, 14.","DOI":"10.3390\/biom14101303"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"123","DOI":"10.4103\/NJPT.NJPT_49_24","article-title":"Harnessing the power of drug repurposing: A promising strategy for drug discovery and development","volume":"2","author":"Athul","year":"2024","journal-title":"Natl. J. Pharmacol. Ther."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1080\/23808993.2024.2393089","article-title":"Drug discovery in the context of precision medicine and artificial intelligence","volume":"9","author":"Hasanzad","year":"2024","journal-title":"Expert. Rev. Precis. Med. Drug Dev."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"5975","DOI":"10.1007\/s10462-022-10306-1","article-title":"Deep learning in drug discovery: An integrative review and future challenges","volume":"56","author":"Askr","year":"2023","journal-title":"Artif. Intell. Rev."},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"e69985","DOI":"10.2196\/69985","article-title":"Explainable AI Approaches in Federated Learning: Systematic Review","volume":"5","author":"Tunduny","year":"2026","journal-title":"JMIR AI"},{"key":"ref_34","doi-asserted-by":"crossref","unstructured":"Qadri, Y.A., Shaikh, S., Ahmad, K., Choi, I., Kim, S.W., and Vasilakos, A.V. (2025). Explainable artificial intelligence: A perspective on drug discovery. Pharmaceutics, 17.","DOI":"10.3390\/pharmaceutics17091119"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/s41573-020-00117-w","article-title":"Image-based profiling for drug discovery: Due for a machine-learning upgrade?","volume":"20","author":"Chandrasekaran","year":"2021","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_36","doi-asserted-by":"crossref","unstructured":"Patel, L., Shukla, T., Huang, X., Ussery, D.W., and Wang, S. (2020). Machine learning methods in drug discovery. Molecules, 25.","DOI":"10.3390\/molecules25225277"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.1017\/qrd.2022.12","article-title":"Applications of machine learning in computer-aided drug discovery","volume":"3","author":"Turzo","year":"2022","journal-title":"QRB Discov."},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1146\/annurev-pharmtox-040323-040828","article-title":"Artificial intelligence for drug discovery: Are we there yet?","volume":"64","author":"Hasselgren","year":"2024","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2174\/1389200219666180820112457","article-title":"Survey of machine learning techniques in drug discovery","volume":"20","author":"Stephenson","year":"2019","journal-title":"Curr. Drug Metab."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Naik, R.R., Shakya, A.K., Aladwan, S.M., and El-Tanani, M. (2022). Kinase inhibitors as potential therapeutic agents in the treatment of COVID-19. Front. Pharmacol., 13.","DOI":"10.3389\/fphar.2022.806568"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"102818","DOI":"10.1016\/j.sbi.2024.102818","article-title":"Deep learning for low-data drug discovery: Hurdles and opportunities","volume":"86","author":"vanTilborg","year":"2024","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1007\/s11030-021-10217-3","article-title":"Artificial intelligence to deep learning: Machine intelligence approach for drug discovery","volume":"25","author":"Gupta","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.imed.2021.10.001","article-title":"Artificial intelligence and machine learning in drug discovery and development","volume":"2","author":"Patel","year":"2022","journal-title":"Intell. Med."},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1208\/s12248-021-00644-3","article-title":"Machine Learning and Artificial Intelligence in Pharmaceutical Research and Development: A Review: Machine Learning and Artificial Intelligence in Pharmaceutical R&D","volume":"24","author":"Kolluri","year":"2022","journal-title":"AAPS J."},{"key":"ref_45","doi-asserted-by":"crossref","unstructured":"Hinkson, I.V., Madej, B., and Stahlberg, E.A. (2020). Accelerating therapeutics for opportunities in medicine: A paradigm shift in drug discovery. Front. Pharmacol., 11.","DOI":"10.3389\/fphar.2020.00770"},{"key":"ref_46","doi-asserted-by":"crossref","unstructured":"Santa Maria, J.P., Wang, Y., and Camargo, L.M. (2023). Perspective on the challenges and opportunities of accelerating drug discovery with artificial intelligence. Front. Bioinform., 3.","DOI":"10.3389\/fbinf.2023.1121591"},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.drudis.2019.03.026","article-title":"Accelerated drug discovery by rapid candidate drug identification","volume":"24","author":"Lindmark","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_48","doi-asserted-by":"crossref","unstructured":"Lee, W.H. (2015). Open access target validation is a more efficient way to accelerate drug discovery. PLoS Biol., 13.","DOI":"10.1371\/journal.pbio.1002164"},{"key":"ref_49","doi-asserted-by":"crossref","unstructured":"Yao, R., Shen, Z., Xu, X., Ling, G., Xiang, R., Song, T., Zhai, F., and Zhai, Y. (2024). Knowledge mapping of graph neural networks for drug discovery: A bibliometric and visualized analysis. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1393415"},{"key":"ref_50","first-page":"2739","article-title":"KGNN: Knowledge graph neural network for drug-drug interaction prediction","volume":"Volume 380","author":"Lin","year":"2020","journal-title":"IJCAI\u201920: Proceedings of the Twenty-Ninth International Conference on International Joint Conferences on Artificial Intelligence"},{"key":"ref_51","doi-asserted-by":"crossref","unstructured":"Su, C., Hou, Y., and Wang, F. (2022). GNN-based Biomedical Knowledge Graph mining in drug development. Graph Neural Networks: Foundations, Frontiers, and Applications, Springer Nature.","DOI":"10.1007\/978-981-16-6054-2_24"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1021\/acs.chemrev.5c00461","article-title":"Graph neural networks in modern AI-aided drug discovery","volume":"125","author":"Zhang","year":"2025","journal-title":"Chem. Rev."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"107900","DOI":"10.1016\/j.compbiomed.2023.107900","article-title":"An effective framework for predicting drug\u2013drug interactions based on molecular substructures and knowledge graph neural network","volume":"169","author":"Chen","year":"2024","journal-title":"Comput. Biol. Med."},{"key":"ref_54","first-page":"2","article-title":"High-throughput screening: The hits and leads of drug discovery-an overview","volume":"1","author":"Martis","year":"2011","journal-title":"J. Appl. Pharm. Sci."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"427","DOI":"10.3390\/ijms13010427","article-title":"Adaptation of high-throughput screening in drug discovery\u2014Toxicological screening tests","volume":"13","author":"Markowicz","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_56","first-page":"112","article-title":"Review on: High-throughput screening is an approach to drug discovery","volume":"4","author":"Hajare","year":"2013","journal-title":"Am. J. Pharm. Tech. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1007\/s12094-006-0048-2","article-title":"High throughput screening in drug discovery","volume":"8","author":"Carnero","year":"2006","journal-title":"Clin. Transl. Oncol."},{"key":"ref_58","doi-asserted-by":"crossref","unstructured":"Aldewachi, H., Al-Zidan, R.N., Conner, M.T., and Salman, M.M. (2021). High-throughput screening platforms in the discovery of novel drugs for neurodegenerative diseases. Bioengineering, 8.","DOI":"10.3390\/bioengineering8020030"},{"key":"ref_59","doi-asserted-by":"crossref","unstructured":"Roy, A. (2022). High-Throughput screening (HTS) technology. Encyclopedia of Molecular Pharmacology, Springer International Publishing.","DOI":"10.1007\/978-3-030-21573-6_73-1"},{"key":"ref_60","doi-asserted-by":"crossref","unstructured":"Barcelos, M.P., Gomes, S.Q., Federico, L.B., Francischini, I.A.G., Hage-Melim, L.I.D.S., Silva, G.M., and de Paula da Silva, C.H.T. (2022). Lead optimization in drug discovery. Research Topics in Bioactivity, Environment and Energy: Experimental and Theoretical Tools, Springer International Publishing.","DOI":"10.1007\/978-3-031-07622-0_19"},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/S1359-6446(03)02726-0","article-title":"Chemistry challenges in lead optimization: Silicon isosteres in drug discovery","volume":"8","author":"Showell","year":"2003","journal-title":"Drug Discov. Today"},{"key":"ref_62","doi-asserted-by":"crossref","unstructured":"Heifetz, A., Southey, M., Morao, I., Townsend-Nicholson, A., and Bodkin, M.J. (2017). Computational methods used in hit-to-lead and lead optimization stages of structure-based drug discovery. Computational Methods for GPCR Drug Discovery, Springer.","DOI":"10.1007\/978-1-4939-7465-8_19"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"bbaf533","DOI":"10.1093\/bib\/bbaf533","article-title":"Computational toxicology in drug discovery: Applications of artificial intelligence in ADMET and toxicity prediction","volume":"26","author":"Zhang","year":"2025","journal-title":"Brief. Bioinform."},{"key":"ref_64","doi-asserted-by":"crossref","first-page":"btae416","DOI":"10.1093\/bioinformatics\/btae416","article-title":"ADMET-AI: A machine learning ADMET platform for evaluation of large-scale chemical libraries","volume":"40","author":"Swanson","year":"2024","journal-title":"Bioinformatics"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"587","DOI":"10.4155\/fmc-2024-0007","article-title":"BioPrint meets the AI age: Development of artificial intelligence-based ADMET models for the drug-discovery platform SAFIRE","volume":"16","author":"Biehn","year":"2024","journal-title":"Future Med. Chem."},{"key":"ref_66","doi-asserted-by":"crossref","unstructured":"Han, R., Yoon, H., Kim, G., Lee, H., and Lee, Y. (2023). Revolutionizing medicinal chemistry: The application of artificial intelligence (AI) in early drug discovery. Pharmaceuticals, 16.","DOI":"10.3390\/ph16091259"},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"e1568","DOI":"10.1002\/wcms.1568","article-title":"Machine learning in drug design: Use of artificial intelligence to explore the chemical structure\u2013biological activity relationship","volume":"12","author":"Staszak","year":"2022","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Bhisetti, G., and Fang, C. (2021). Artificial intelligence\u2013enabled de novo design of novel compounds that are synthesizable. Artificial Intelligence in Drug Design, Springer.","DOI":"10.1007\/978-1-0716-1787-8_17"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1080\/17460441.2021.1915982","article-title":"Critical assessment of AI in drug discovery","volume":"16","author":"Walters","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_70","unstructured":"Rohith Reddy, G.K., Ibrahim, S.A., and Ali, S.J. (2026). ADMET-X: Machine Learning Framework for Predicting Pharmacokinetic and Toxicological Drug Properties. 2026 International Conference on AI-Driven Smart Systems and Ubiquitous Computing (ICAUC), IEEE."},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"1","DOI":"10.33160\/yam.2026.02.001","article-title":"Next-Generation Artificial Intelligence for ADME Prediction in Drug Discovery: From Small Molecules to Biologics","volume":"69","author":"Tanihata","year":"2026","journal-title":"Yonago Acta Medica"},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"23643","DOI":"10.1021\/acs.jmedchem.5c03159","article-title":"A New Era of Artificial Intelligence (AI): Transforming Drug Discovery and Development","volume":"68","author":"Ali","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"A4147781","DOI":"10.1161\/circ.150.suppl_1.4147781","article-title":"ADMET-AI enables interpretable predictions of drug-induced cardiotoxicity","volume":"150","author":"Swanson","year":"2024","journal-title":"Circulation"},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.drudis.2020.12.009","article-title":"Artificial intelligence in drug discovery: What is realistic, what are illusions? Part 1: Ways to make an impact, and why we are not there yet","volume":"26","author":"Bender","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_75","doi-asserted-by":"crossref","unstructured":"Mak, K.K., Wong, Y.H., and Pichika, M.R. (2024). Artificial intelligence in drug discovery and development. Drug Discovery and Evaluation: Safety and Pharmacokinetic Assays, Springer.","DOI":"10.1007\/978-3-031-35529-5_92"},{"key":"ref_76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1089\/adt.2008.150","article-title":"A robotic platform for quantitative high-throughput screening","volume":"6","author":"Michael","year":"2008","journal-title":"Assay. Drug Dev. Technol."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2174\/1570180812666150414215346","article-title":"A Review on Recent Robotic and Analytic Technologies in High Throughput Screening and Synthesis for Drug Discovery","volume":"12","author":"Zhu","year":"2015","journal-title":"Lett. Drug Des. Discov."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1057\/palgrave.jcb.3040134","article-title":"The role of research institutions in the formation of the biotech cluster in Massachusetts: The MIT experience","volume":"11","author":"Nelsen","year":"2005","journal-title":"J. Commer. Biotechnol."},{"key":"ref_79","doi-asserted-by":"crossref","unstructured":"Sarkar, C., Das, B., Rawat, V.S., Wahlang, J.B., Nongpiur, A., Tiewsoh, I., Lyngdoh, N.M., Das, D., Bidarolli, M., and Sony, H.T. (2023). Artificial intelligence and machine learning technology driven modern drug discovery and development. Int. J. Mol. Sci., 24.","DOI":"10.3390\/ijms24032026"},{"key":"ref_80","first-page":"250","article-title":"Artificial Intelligence and Robotics: A Step Forward Towards Drug Discovery","volume":"20","author":"Tiwari","year":"2022","journal-title":"Neuroquantology"},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41573-019-0024-5","article-title":"Applications of machine learning in drug discovery and development","volume":"18","author":"Vamathevan","year":"2019","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"175260","DOI":"10.1016\/j.ejphar.2022.175260","article-title":"Deep learning and machine intelligence: New computational modeling techniques for discovery of the combination rules and pharmacodynamic characteristics of Traditional Chinese Medicine","volume":"933","author":"Li","year":"2022","journal-title":"Eur. J. Pharmacol."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1016\/j.drudis.2021.01.008","article-title":"Integration of AI and traditional medicine in drug discovery","volume":"26","author":"Khan","year":"2021","journal-title":"Drug Discov. Today"},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3390\/ai5030074","article-title":"Understanding physics-informed neural networks: Techniques, applications, trends, and challenges","volume":"5","author":"Farea","year":"2024","journal-title":"AI"},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1109\/TPWRS.2022.3162473","article-title":"Applications of physics-informed neural networks in power systems-a review","volume":"38","author":"Huang","year":"2022","journal-title":"IEEE Trans. Power Syst."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"8569","DOI":"10.1021\/acs.jctc.4c00764","article-title":"Enhanced sampling of biomolecular slow conformational transitions using adaptive sampling and machine learning","volume":"20","author":"Zhang","year":"2024","journal-title":"J. Chem. Theory Comput."},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"12551","DOI":"10.1021\/acs.jcim.5c01581","article-title":"How Feasible Is Docking of PROTACs to POI-E3L Complexes? Testing Physics-Based and ML-Based Docking Tools","volume":"65","author":"Pallara","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"105740","DOI":"10.1016\/j.antiviral.2023.105740","article-title":"Artificial intelligence: Machine learning approach for screening large database and drug discovery","volume":"220","author":"Parvatikar","year":"2023","journal-title":"Antivir. Res."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"7016","DOI":"10.1039\/D5CC06025G","article-title":"Innovative integration of molecular docking and machine learning for drug discovery: From virtual screening to nanomolar inhibitors","volume":"62","author":"Taha","year":"2026","journal-title":"Chem. Commun."},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1080\/17460441.2025.2508866","article-title":"On the application of artificial intelligence in virtual screening","volume":"20","author":"Thaingtamtanha","year":"2025","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_91","unstructured":"Nasim, I., and Nasim, A. (2024). Discovering intrinsic multi-compartment pharmacometric models using Physics Informed Neural Networks. arXiv."},{"key":"ref_92","doi-asserted-by":"crossref","unstructured":"Awojoyogbe, B.O., and Dada, M.O. (2024). Physics Informed Neural Networks (PINNs). Digital Molecular Magnetic Resonance Imaging, Springer Nature.","DOI":"10.1007\/978-981-97-6370-2"},{"key":"ref_93","doi-asserted-by":"crossref","unstructured":"Azam, F., and Almahmoud, S.A. (2026). Open-Source Molecular Docking and AI-Augmented Structure-Based Drug Design: Current Workflows, Challenges, and Opportunities. Int. J. Mol. Sci., 27.","DOI":"10.3390\/ijms27073302"},{"key":"ref_94","first-page":"171","article-title":"AI for Drug Discovery: From Algorithms to Medicines","volume":"3","author":"Khurshid","year":"2025","journal-title":"J. Pharm. Biomed."},{"key":"ref_95","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrd.2016.123","article-title":"Biophysics in drug discovery: Impact, challenges and opportunities","volume":"15","author":"Renaud","year":"2016","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_96","doi-asserted-by":"crossref","first-page":"e81552","DOI":"10.2196\/81552","article-title":"Accelerating Discovery of Leukemia Inhibitors Using AI-Driven Quantitative Structure-Activity Relationship: Algorithm Development and Validation","volume":"5","author":"Kakraba","year":"2026","journal-title":"JMIR AI"},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1021\/acs.jmedchem.4c03044","article-title":"Real-World Applications and Experiences of AI\/ML Deployment for Drug Discovery","volume":"68","author":"Pitt","year":"2025","journal-title":"J. Med. Chem."},{"key":"ref_98","doi-asserted-by":"crossref","unstructured":"Jiao, R., Zhang, S., Zhang, H., Deng, B., Zhang, T., Tang, S., Hu, X., and Zhang, W. (2026). Physics\u2013Data-Integrated Hybrid Simulation for Transient Stability in New Power Systems: Status, Challenges, and Prospects. Energies, 19.","DOI":"10.3390\/en19071687"},{"key":"ref_99","first-page":"1","article-title":"Integrating Artificial Intelligence into the Higher Education of Physics: Theoretical Frameworks and Pedagogical Strategies","volume":"1","author":"Kotsis","year":"2025","journal-title":"Gabaldon Int. J. Educ. Methodol."},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"041304","DOI":"10.1063\/5.0260078","article-title":"From QM\/MM to ML\/MM: A new era in multiscale modeling","volume":"6","author":"Grassano","year":"2025","journal-title":"Chem. Phys. Rev."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"103191","DOI":"10.1016\/j.sbi.2025.103191","article-title":"Recent advances in artificial intelligence\u2013driven biomolecular dynamics simulations based on machine learning force fields","volume":"95","author":"Cui","year":"2025","journal-title":"Curr. Opin. Struct. Biol."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"035101","DOI":"10.1063\/5.0147023","article-title":"Improving machine learning force fields for molecular dynamics simulations with fine-grained force metrics","volume":"159","author":"Wang","year":"2023","journal-title":"J. Chem. Phys."},{"key":"ref_103","unstructured":"Huang, K., Fu, T., Gao, W., Zhao, Y., Roohani, Y., Leskovec, J., Coley, C.W., Xiao, C., Sun, J., and Zitnik, M. (2021). Therapeutics data commons: Machine learning datasets and tasks for drug discovery and development. arXiv."},{"key":"ref_104","doi-asserted-by":"crossref","unstructured":"Niazi, S.K. (2025). Quantum mechanics in drug discovery: A comprehensive review of methods, applications, and future directions. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26136325"},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s44371-025-00363-0","article-title":"Advancing predictive modeling in computational chemistry through quantum chemistry, molecular mechanics, and machine learning","volume":"2","author":"Rowaiye","year":"2025","journal-title":"Discov. Chem."},{"key":"ref_106","doi-asserted-by":"crossref","unstructured":"Catlow, C.R.A., Buckeridge, J., Farrow, M.R., Logsdail, A.J., and Sokol, A.A. (2017). Quantum Mechanical\/Molecular Mechanical (QM\/MM) Approaches, Wiley.","DOI":"10.1002\/9783527691036.hsscvol5012"},{"key":"ref_107","doi-asserted-by":"crossref","unstructured":"Rothlisberger, U., and Carloni, P. (2006). Drug-target binding investigated by quantum mechanical\/molecular mechanical (QM\/MM) methods. Computer Simulations in Condensed Matter Systems: From Materials to Chemical Biology Volume 2, Springer.","DOI":"10.1007\/3-540-35284-8_17"},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"86","DOI":"10.14419\/h2b67b51","article-title":"Quantum mechanics\/molecular mechanics (QM\/MM) methods in drug design: A comprehensive review of development and applications","volume":"12","author":"Mohammed","year":"2024","journal-title":"Int. J. Adv. Chem."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1517\/17460441.2015.1076389","article-title":"Simulation with quantum mechanics\/molecular mechanics for drug discovery","volume":"10","author":"Barbault","year":"2015","journal-title":"Exper. Opin. Drug Discov."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.1021\/bi400215w","article-title":"Combined quantum mechanics\/molecular mechanics (QM\/MM) methods in computational enzymology","volume":"52","author":"Mulholland","year":"2013","journal-title":"Biochemistry"},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1007\/s12257-020-0049-y","article-title":"Artificial intelligence in drug discovery: A comprehensive review of data-driven and machine learning approaches","volume":"25","author":"Kim","year":"2020","journal-title":"Biotechnol. Bioprocess. Eng."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"9398","DOI":"10.1021\/acs.jcim.5c01609","article-title":"Practically significant method comparison protocols for machine learning in small molecule drug discovery","volume":"65","author":"Ash","year":"2025","journal-title":"J. Chem. Inf. Model."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"892","DOI":"10.51594\/csitrj.v5i4.1048","article-title":"Machine Learning in Drug Discovery: A critical review of applications and challenges","volume":"5","author":"Udegbe","year":"2024","journal-title":"Comput. Sci. IT Res. J."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1016\/j.drudis.2017.08.010","article-title":"From machine learning to deep learning: Progress in machine intelligence for rational drug discovery","volume":"22","author":"Zhang","year":"2017","journal-title":"Drug Discov. Today"},{"key":"ref_115","doi-asserted-by":"crossref","unstructured":"Qi, X., Zhao, Y., Qi, Z., Hou, S., and Chen, J. (2024). Machine learning empowering drug discovery: Applications, opportunities and challenges. Molecules, 29.","DOI":"10.3390\/molecules29040903"},{"key":"ref_116","doi-asserted-by":"crossref","first-page":"245","DOI":"10.4155\/fmc-2021-0243","article-title":"Machine learning and deep learning in data-driven decision making of drug discovery and challenges in high-quality data acquisition in the pharmaceutical industry","volume":"14","author":"Kumar","year":"2022","journal-title":"Future Med. Chem."},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1007\/s10462-021-10058-4","article-title":"Machine learning in drug discovery: A review","volume":"55","author":"Dara","year":"2022","journal-title":"Artif. Intell. Rev."},{"key":"ref_118","first-page":"e44359","article-title":"Artificial intelligence and machine learning in pharmacological research: Bridging the gap between data and drug discovery","volume":"15","author":"Singh","year":"2023","journal-title":"Cureus"},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"e1513","DOI":"10.1002\/wcms.1513","article-title":"Machine learning, artificial intelligence, and data science breaking into drug design and neglected diseases","volume":"11","author":"Nguewa","year":"2021","journal-title":"Wiley Interdiscip. Rev. Comput. Mol. Sci."},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"631","DOI":"10.2174\/18735592MTEzsMDMnz","article-title":"Artificial intelligence, big data and machine learning approaches in precision medicine & drug discovery","volume":"22","author":"Nayarisseri","year":"2021","journal-title":"Curr. Drug Targets"},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"e70056","DOI":"10.1111\/cts.70056","article-title":"Practical guide to SHAP analysis: Explaining supervised machine learning model predictions in drug development","volume":"17","author":"Schmitt","year":"2024","journal-title":"Clin. Transl. Sci."},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"105752","DOI":"10.1016\/j.bspc.2023.105752","article-title":"Exploring explainable machine learning and Shapley additive exPlanations (SHAP) technique to uncover key factors of HNSC cancer: An analysis of the best practices","volume":"89","author":"Miao","year":"2024","journal-title":"Biomed. Signal Process. Control"},{"key":"ref_123","first-page":"3784","article-title":"Enhancing Quantitative Structure--Activity Relationship Predictive Power and Explainability: Meta-Modeling and Shapley Additive Explanations Feature Importance Analysis for Drug Discovery","volume":"9","author":"Sanjaya","year":"2025","journal-title":"Trop. J. Nat. Prod. Res."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1016\/j.drudis.2019.07.006","article-title":"Deep learning in drug discovery: Opportunities, challenges and future prospects","volume":"24","author":"Lavecchia","year":"2019","journal-title":"Drug Discov. Today"},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"e003","DOI":"10.48130\/targetome-0026-0001","article-title":"Data-driven targetome discovery and database requirements: Insights from the therapeutic target database","volume":"2","author":"Shan","year":"2026","journal-title":"Targetome"},{"key":"ref_126","doi-asserted-by":"crossref","unstructured":"Mallon, A.-M., H\u00e4ring, D.A., Dahlke, F., Aarden, P., Afyouni, S., Delbarre, D., El Emam, K., Ganjgahi, H., Gardiner, S., and Kwok, C.H. (2021). Advancing data science in drug development through an innovative computational framework for data sharing and statistical analysis. BMC Med. Res. Methodol., 21.","DOI":"10.1186\/s12874-021-01409-4"},{"key":"ref_127","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/jrsm.1453","article-title":"Assessing context suitability (generalizability, external validity, applicability or transferability) of findings in evidence syntheses in healthcare\u2014An integrative review of methodological guidance","volume":"11","author":"Weise","year":"2020","journal-title":"Res. Synth. Methods"},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1080\/17460441.2021.1901685","article-title":"The challenges of generalizability in artificial intelligence for ADME\/Tox endpoint and activity prediction","volume":"16","author":"Huang","year":"2021","journal-title":"Expert Opin. Drug Discov."},{"key":"ref_129","doi-asserted-by":"crossref","unstructured":"Xia, X., Zhu, C., Zhong, F., and Liu, L. (2024). TransCDR: A deep learning model for enhancing the generalizability of drug activity prediction through transfer learning and multimodal data fusion. BMC Biol., 22.","DOI":"10.1186\/s12915-024-02023-8"},{"key":"ref_130","doi-asserted-by":"crossref","first-page":"105388","DOI":"10.1016\/j.yrtph.2023.105388","article-title":"Artificial intelligence and real-world data for drug and food safety\u2013A regulatory science perspective","volume":"140","author":"Thakkar","year":"2023","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_131","doi-asserted-by":"crossref","first-page":"lsaf028","DOI":"10.1093\/jlb\/lsaf028","article-title":"The future of AI regulation in drug development: A comparative analysis","volume":"12","author":"Lenarczyk","year":"2025","journal-title":"J. Law Biosci."},{"key":"ref_132","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1002\/cpt.1617","article-title":"Are the European Medicines Agency, US Food and Drug Administration, and other international regulators talking to each other?","volume":"107","author":"Teixeira","year":"2020","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_133","doi-asserted-by":"crossref","first-page":"100231","DOI":"10.1016\/j.mcpdig.2025.100231","article-title":"United States Food and Drug Administration regulation of clinical software in the era of artificial intelligence and machine learning","volume":"3","author":"Singh","year":"2025","journal-title":"Mayo Clin. Proc. Digit. Health"},{"key":"ref_134","doi-asserted-by":"crossref","unstructured":"Hu, Z., Bhutto, J.A., Ishfaq, M., Shah, S.W.A., Bilawal, A., Shah, Z., and Guan, Y. (2025). Ethical considerations in the application of machine learning and artificial intelligence in medicinal chemistry, pharmacology, and toxicology. Computational Methods in Medicinal Chemistry, Pharmacology, and Toxicology, Academic Press.","DOI":"10.1016\/B978-0-443-33024-7.00003-5"},{"key":"ref_135","doi-asserted-by":"crossref","first-page":"e37093","DOI":"10.12681\/jpentai.37093","article-title":"Ethical Issues Arising from the Use of AI in Drug Discovery","volume":"3","author":"Anastasopoulou","year":"2024","journal-title":"J. Politics Ethics New Technol. Artif. Intell."},{"key":"ref_136","doi-asserted-by":"crossref","unstructured":"Al-Worafi, Y.M. (2023). Artificial intelligence and machine learning for drug safety. Technology for Drug Safety: Current Status and Future Developments, Springer International Publishing.","DOI":"10.1007\/978-3-031-34268-4"},{"key":"ref_137","doi-asserted-by":"crossref","first-page":"FDD59","DOI":"10.4155\/fdd-2020-0028","article-title":"Artificial intelligence in drug design: Algorithms, applications, challenges and ethics","volume":"3","author":"Arabi","year":"2021","journal-title":"Future Drug Discov."},{"key":"ref_138","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/jamiaopen\/ooz046","article-title":"Overcoming barriers to the adoption and implementation of predictive modeling and machine learning in clinical care: What can we learn from US academic medical centers?","volume":"3","author":"Watson","year":"2020","journal-title":"JAMIA Open"},{"key":"ref_139","doi-asserted-by":"crossref","first-page":"102295","DOI":"10.1016\/j.omtn.2024.102295","article-title":"The changing scenario of drug discovery using AI to deep learning: Recent advancement, success stories, collaborations, and challenges","volume":"35","author":"Chakraborty","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_140","doi-asserted-by":"crossref","first-page":"23889","DOI":"10.1021\/acsomega.5c00549","article-title":"AI-driven drug discovery: A comprehensive review","volume":"10","author":"Ferreira","year":"2025","journal-title":"ACS Omega"},{"key":"ref_141","first-page":"61","article-title":"The AI-driven future of drug discovery: Innovations, applications, and challenges","volume":"15","author":"Pache","year":"2025","journal-title":"Asian J. Res. Pharm. Sci."},{"key":"ref_142","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.21608\/ejchem.2024.337877.10835","article-title":"The role of artificial intelligence in drug discovery and development","volume":"67","author":"Ozaybi","year":"2024","journal-title":"Egypt. J. Chem."},{"key":"ref_143","first-page":"668","article-title":"Revolutionizing drug development: AI-driven predictive modeling for accelerated small molecule and biologic therapeutics","volume":"33","author":"Patel","year":"2024","journal-title":"Well Test. J."},{"key":"ref_144","doi-asserted-by":"crossref","unstructured":"Koirala, M., Yan, L., Mohamed, Z., and DiPaola, M. (2025). AI-Integrated QSAR modeling for enhanced drug discovery: From classical approaches to deep learning and structural insight. Int. J. Mol. Sci., 26.","DOI":"10.3390\/ijms26199384"},{"key":"ref_145","doi-asserted-by":"crossref","first-page":"35","DOI":"10.63125\/j1hbts51","article-title":"In Silico drug repurposing for inflammatory diseases: A systematic review of molecular docking and virtual screening studies","volume":"2","author":"Enni","year":"2022","journal-title":"Am. J. Adv. Technol. Eng. Solut."},{"key":"ref_146","doi-asserted-by":"crossref","unstructured":"Gangwal, A., Ansari, A., Ahmad, I., Azad, A.K., Kumarasamy, V., Subramaniyan, V., and Wong, L.S. (2024). Generative artificial intelligence in drug discovery: Basic framework, recent advances, challenges, and opportunities. Front. Pharmacol., 15.","DOI":"10.3389\/fphar.2024.1331062"},{"key":"ref_147","doi-asserted-by":"crossref","unstructured":"Lavecchia, A. (2025). Transform drug discovery and development with generative artificial intelligence. Generative Artificial Intelligence for Biomedical and Smart Health Informatics, Wiley.","DOI":"10.1002\/9781394280735.ch25"},{"key":"ref_148","first-page":"120","article-title":"The future of drug discovery utilizing generative AI and big data analytics for accelerating pharmaceutical innovations","volume":"14","author":"Manik","year":"2018","journal-title":"Nanotechnol. Percept."},{"key":"ref_149","doi-asserted-by":"crossref","first-page":"e02448","DOI":"10.1002\/slct.202502448","article-title":"Transforming precision medicine through generative AI: Advanced architectures and tailored therapeutic design for patient-specific drug discovery","volume":"10","author":"Das","year":"2025","journal-title":"ChemistrySelect"},{"key":"ref_150","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1208\/s12248-021-00593-x","article-title":"Application of machine learning in translational medicine: Current status and future opportunities","volume":"23","author":"Terranova","year":"2021","journal-title":"AAPS J."},{"key":"ref_151","doi-asserted-by":"crossref","first-page":"1688637","DOI":"10.1155\/sci5\/1688637","article-title":"Computational Landscape in Drug Discovery: From AI\/ML Models to Translational Application","volume":"2025","author":"Sharma","year":"2025","journal-title":"Scientifica"},{"key":"ref_152","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1002\/cpt.3152","article-title":"Current status and future directions: The application of artificial intelligence\/machine learning for precision medicine","volume":"115","author":"Naik","year":"2024","journal-title":"Clin. Pharmacol. Ther."},{"key":"ref_153","doi-asserted-by":"crossref","unstructured":"Uddin, M.R., Sovon, M.S.I., Mondal, S., Ahmed, S., Al-Mizan, M.A., Aktar, F., and Amran, M.S. (2025). Artificial intelligence and machine learning in pharmaceutical sciences: Unpacking regulatory guidance, opportunities, and challenges for safe and effective drug development. Int. J. Med. Inform.","DOI":"10.2139\/ssrn.5505018"},{"key":"ref_154","doi-asserted-by":"crossref","unstructured":"Agarwal, B., Gaware, S., More, N., Shinde, R., Shivakumar, H.N., and Jagdale, S. (2026). A Review Exploring the Translational Perspective of Artificial Intelligence in Drug Discovery and Formulation Development. Ann. Pharm. Fran\u00e7aises, Online ahead of print.","DOI":"10.1016\/j.pharma.2026.01.007"},{"key":"ref_155","doi-asserted-by":"crossref","first-page":"102255","DOI":"10.1016\/j.omtn.2024.102255","article-title":"Large language model to multimodal large language model: A journey to shape the biological macromolecules to biological sciences and medicine","volume":"35","author":"Bhattacharya","year":"2024","journal-title":"Mol. Ther. Nucleic Acids"},{"key":"ref_156","unstructured":"Yan, L., Jiang, X., Ma, J., Liu, Y., Bian, T., Wang, Q., Basu, A., Rong, Y., Xu, T., and Wu, P. (2025, January 30). A Comprehensive Survey of Multimodal LLMs for Scientific Discovery. Proceedings of the 1st Workshop on VLM4RWD@ NeurIPS 2025, Mexico City, Mexico."},{"key":"ref_157","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1007\/s13534-025-00497-1","article-title":"From large language models to multimodal AI: A scoping review on the potential of generative AI in medicine","volume":"15","author":"Buess","year":"2025","journal-title":"Biomed. Eng. Lett."},{"key":"ref_158","doi-asserted-by":"crossref","first-page":"27453","DOI":"10.1021\/acs.analchem.5c04083","article-title":"Application and Prospects of Large Language Models in Small-Molecule Drug Discovery","volume":"97","author":"Ma","year":"2025","journal-title":"Anal. Chem."},{"key":"ref_159","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s10822-024-00559-z","article-title":"De novo drug design as GPT language modeling: Large chemistry models with supervised and reinforcement learning","volume":"38","author":"Ye","year":"2024","journal-title":"J. Comput.-Aided Mol. Des."},{"key":"ref_160","doi-asserted-by":"crossref","unstructured":"Gangwal, A., and Lavecchia, A. (2026). Large Language Models in Drug Discovery. Applied Artificial Intelligence for Drug Discovery: From Data-Driven Insights to Therapeutic Innovation, Springer Nature.","DOI":"10.1007\/978-3-031-98022-0"},{"key":"ref_161","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.cbpa.2019.10.003","article-title":"Machine learning for target discovery in drug development","volume":"56","author":"Rodrigues","year":"2020","journal-title":"Curr. Opin. Chem. Biol."},{"key":"ref_162","doi-asserted-by":"crossref","unstructured":"He, J., Hua, C., Wang, Y., and Zheng, Z. (2025). Collaborative intelligence in sequential experiments: A human-in-the-loop framework for drug discovery. Inf. Syst. Res.","DOI":"10.1287\/isre.2024.1154"},{"key":"ref_163","doi-asserted-by":"crossref","unstructured":"Shi, C., Ren, X., Wang, Y., Li, J., Sun, Y., Luo, Y., and Sheng, R. (2026). A Survey of Human-AI Collaboration for Scientific Discovery. Preprints.org.","DOI":"10.36227\/techrxiv.176823034.44078313\/v2"},{"key":"ref_164","doi-asserted-by":"crossref","unstructured":"Wang, D., Churchill, E., Maes, P., Fan, X., Shneiderman, B., Shi, Y., and Wang, Q. (2020). From human-human collaboration to Human-AI collaboration: Designing AI systems that can work together with people. Extended Abstracts of the 2020 CHI Conference on Human Factors in Computing Systems, IBM.","DOI":"10.1145\/3334480.3381069"},{"key":"ref_165","doi-asserted-by":"crossref","first-page":"103985","DOI":"10.1016\/j.drudis.2024.103985","article-title":"The present state and challenges of active learning in drug discovery","volume":"29","author":"Wang","year":"2024","journal-title":"Drug Discov. Today"},{"key":"ref_166","doi-asserted-by":"crossref","unstructured":"Avramouli, M., Savvas, I.K., Vasilaki, A., and Garani, G. (2023). Unlocking the potential of quantum machine learning to advance drug discovery. Electronics, 12.","DOI":"10.20944\/preprints202305.0473.v1"},{"key":"ref_167","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1016\/j.drudis.2016.06.026","article-title":"Open for collaboration: An academic platform for drug discovery and development at SciLifeLab","volume":"21","author":"Arvidsson","year":"2016","journal-title":"Drug Discov. Today"},{"key":"ref_168","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1039\/D4PM00323C","article-title":"AI-driven innovations in pharmaceuticals: Optimizing drug discovery and industry operations","volume":"2","author":"Saini","year":"2025","journal-title":"RSC Pharm."},{"key":"ref_169","doi-asserted-by":"crossref","unstructured":"Blanco-Gonzalez, A., Cabezon, A., Seco-Gonzalez, A., Conde-Torres, D., Antelo-Riveiro, P., Pineiro, A., and Garcia-Fandino, R. (2023). The role of AI in drug discovery: Challenges, opportunities, and strategies. Pharmaceuticals, 16.","DOI":"10.3390\/ph16060891"},{"key":"ref_170","doi-asserted-by":"crossref","unstructured":"Garg, S., Arora, K., Singh, S., and Nagarajan, K. (2024). Artificial intelligence and machine learning in drug discovery and development. Artificial Intelligence in the Age of Nanotechnology, IGI Global Scientific Publishing.","DOI":"10.4018\/979-8-3693-0368-9.ch003"},{"key":"ref_171","doi-asserted-by":"crossref","unstructured":"Visan, A.I., and Negut, I. (2024). Integrating artificial intelligence for drug discovery in the context of revolutionizing drug delivery. Life, 14.","DOI":"10.3390\/life14020233"},{"key":"ref_172","doi-asserted-by":"crossref","unstructured":"Vora, L.K., Gholap, A.D., Jetha, K., Thakur, R.R.S., Solanki, H.K., and Chavda, V.P. (2023). Artificial intelligence in pharmaceutical technology and drug delivery design. Pharmaceutics, 15.","DOI":"10.3390\/pharmaceutics15071916"},{"key":"ref_173","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.2174\/0115680266324522240725053634","article-title":"Impact of artificial intelligence on drug development and delivery","volume":"25","author":"Aundhia","year":"2025","journal-title":"Curr. Top. Med. Chem."},{"key":"ref_174","doi-asserted-by":"crossref","unstructured":"Asediya, V., Anjaria, P., Dhial, K., and Pathak, A. (2025). Artificial Intelligence and Machine Learning in Drug Delivery Optimization. Next-Generation Drug Delivery Systems, Springer.","DOI":"10.1007\/978-1-0716-4554-3_22"},{"key":"ref_175","doi-asserted-by":"crossref","unstructured":"Rabbani, S.A., El-Tanani, M., Sharma, S., Rabbani, S.S., El-Tanani, Y., Kumar, R., and Saini, M. (2025). Generative artificial intelligence in healthcare: Applications, implementation challenges, and future directions. BioMedInformatics, 5.","DOI":"10.3390\/biomedinformatics5030037"},{"key":"ref_176","doi-asserted-by":"crossref","unstructured":"Rabbani, S.A., El-Tanani, M., El-Tanani, Y., Kumar, R., Sharma, S., Khan, M.A., Parvez, S., Aljabali, A.A.A., Matalka, M.I., and Rizzo, M. (2025). Advances in Adoptive Cell Therapies in Cancer: From Mechanistic Breakthroughs to Clinical Frontiers and Overcoming Barriers. Med. Sci., 13.","DOI":"10.3390\/medsci13030190"}],"container-title":["Pharmaceuticals"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/810\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,25]],"date-time":"2026-05-25T05:36:46Z","timestamp":1779687406000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1424-8247\/19\/6\/810"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,22]]},"references-count":176,"journal-issue":{"issue":"6","published-online":{"date-parts":[[2026,6]]}},"alternative-id":["ph19060810"],"URL":"https:\/\/doi.org\/10.3390\/ph19060810","relation":{},"ISSN":["1424-8247"],"issn-type":[{"value":"1424-8247","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,22]]}}}